Kymera Therapeutics, Inc. Share Price
NASDAQ: KYMR | Mid CapKymera Therapeutics, Inc. Stock Performance
Open $119.03 | Prev. Close $120.73 | Circuit Range N/A |
Day Range $117.58 - $119.87 | Year Range $39.93 - $129.83 | Volume 30,104 |
Average Traded $118.34 |
Kymera Therapeutics, Inc. Share Price Today
As of 30 August 2026, Kymera Therapeutics, Inc.'s share price is $118.23. The stock opened at $119.03, compared to its previous close of $120.73. During today's trading session, Kymera Therapeutics, Inc.'s share price traded between $117.58 and $119.87, with an average price of $118.72. Over the past 52 weeks, the stock has recorded a high of $129.83 and a low of $39.93. In terms of performance, Kymera Therapeutics, Inc.'s share price has risen by 29.38% over the last six months and is up 187.07% on a year-on-year basis.
Kymera Therapeutics, Inc. Share Price Chart
Kymera Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $9.99B | PE Ratio (TTM) -32.04 | Dividend Yield N/A |
EPS (TTM) $-3.69 | Revenue (TTM) $39.21M | Return On Equity (TTM) -19.71% |
Profit Margin -794.04% | Debt to Equity 0.05 | Quarterly Earnings Growth YoY -31.51% |
Kymera Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Kymera Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Kymera Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $100.86 | $120.13 | +16.28% |
Jul 2026 | $114.11 | $103.31 | -9.96% |
Jun 2026 | $80.66 | $114.74 | +40.88% |
May 2026 | $80.78 | $81.44 | +0.46% |
Apr 2026 | $84.45 | $81.07 | -2.68% |
Mar 2026 | $90.05 | $83.31 | -8.84% |
Feb 2026 | $71.60 | $91.38 | +25.71% |
Jan 2026 | $77.83 | $72.69 | -6.48% |
Dec 2025 | $66.75 | $77.73 | +14.49% |
Nov 2025 | $62.99 | $67.89 | +9.73% |
Oct 2025 | $56.69 | $61.87 | +9.22% |
Sep 2025 | $41.13 | $56.65 | +37.54% |
KYMR Share Price FAQs
What is Kymera Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Kymera Therapeutics, Inc. stock?
What is KYMR's market capitalisation today?
What is KYMR's net income for the last quarter?
What is the 5 year returns of KYMR?
What is the high & low stock price of KYMR today?
Can I buy KYMR shares in India?